KRAS and ovarian endometrioid carcinoma: Type I (5–10%) includes low-grade serous, mucinous, clear cell, and endometrioid ovarian carcinomas, are typically KRAS, PIK3CA, PTEN, or BRAF mutated, and diagnosed frequently at early stages.